Kirby Institute
Clinical trials sponsored by Kirby Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New push to bring hepatitis c treatment to drug clinics Results expected Dec 2026 (estimated)
- When to boost? new trial seeks best COVID-19 shot timing for vulnerable patients Results expected Dec 2026 (estimated)
- Could a diabetes drug curb ice addiction? new trial aims to find out Results expected Jan 2027 (estimated)
-
Could a diabetes drug curb ice addiction? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial will test whether semaglutide, the drug in Ozempic, can help people with methamphetamine use disorder cut down their use. Forty adults who use methamphetamine at least 14 days per month will receive weekly injections for 12 weeks. The study will check if the tr…
Phase 2 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New antibiotic strategy could shorten hospital stays for heart infections
Disease control Not yet recruitingThis pilot study tests a long-acting antibiotic called oritavancin for treating gram-positive heart infections, such as infective endocarditis. The goal is to see if weekly IV doses can replace the usual weeks-long hospital stays and daily antibiotics. The study will enroll 20 ad…
Phase 2 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could Self-Swabs make anal cancer screening easier for people with HIV?
Knowledge-focused Not yet recruitingThis trial tests whether people living with HIV can collect their own anal swabs for anal cancer screening, compared with swabs taken by a clinician. About 700 participants in Australia will provide both types of swabs, which will be checked for high-risk HPV and precancerous cel…
Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC